1. Home /
  2. Personal injury lawyer /
  3. Rheingold Giuffra Ruffo & Plotkin LLP

Category



General Information

Locality: New York, New York

Phone: +1 212-684-1880



Address: 551 5th Avenue, 29th Floor 10017 New York, NY, US

Website: www.rheingoldlaw.com

Likes: 94

Reviews

Add review



Facebook Blog

Rheingold Giuffra Ruffo & Plotkin LLP 14.11.2020

After a seven month hiatus due to the COVID-19 pandemic, jury trials are scheduled to resume in New York City. The first civil jury trials began this past Monday and criminal jury trials are scheduled to commence on October 26, 2020. Learn more on our blog: #newyorkcity #jury

Rheingold Giuffra Ruffo & Plotkin LLP 12.11.2020

Purdue Pharma, the maker of OxyContin, has agreed to plead guilty to criminal charges related to its marketing of the addictive painkiller, and faces penalties of roughly $8.3 billion. #OxyContin

Rheingold Giuffra Ruffo & Plotkin LLP 04.11.2020

The European Medicines Agency (EMA) recently issued a press release to announce it has confirmed prior recommendations to suspend ranitidine from the market. Read more on our site:

Rheingold Giuffra Ruffo & Plotkin LLP 22.10.2020

Johnson & Johnson's clinical trial concerning a COVID-19 vaccine has been paused after one of the trial participants became ill. #johnsonandjohnson #vaccines #COVID19

Rheingold Giuffra Ruffo & Plotkin LLP 08.10.2020

The Child Victims Act keeps the courts open through August 14, 2021. In the first eight months of the Child Victims Act, nearly 1,800 cases were already being filed in New York. Read more on our blog.

Rheingold Giuffra Ruffo & Plotkin LLP 24.09.2020

The growing number of Paragard lawsuits has compelled the women injured by the contraceptive device to petition to have their civil lawsuits consolidated before one U.S. District Judge for coordinated pretrial proceedings. #Paragard #lawsuits

Rheingold Giuffra Ruffo & Plotkin LLP 17.09.2020

With the impending end of Daylight Savings Time on November 1, 2020, a medical journal has published a study that confirms lack of sleep for healthcare workers can lead to an increase in medical errors and medical malpractice. Read more here:

Rheingold Giuffra Ruffo & Plotkin LLP 04.09.2020

Teva Pharmaceuticals has already been warned about its inaccurate marketing of Paragard. The fact that Paragard's defects often lead to surgery may be an indicator that the device is too dangerous to be kept on the market.

Rheingold Giuffra Ruffo & Plotkin LLP 30.08.2020

As more women are experiencing serious problems with the Paragard IUD, lawsuits against the manufacturer are mounting. One such lawsuit was filed last week in New York.

Rheingold Giuffra Ruffo & Plotkin LLP 14.08.2020

What many have believed has now been confirmed by public records. New York City officials have minimized the presence and danger of lead paint in the city's public housing facilities.

Rheingold Giuffra Ruffo & Plotkin LLP 29.07.2020

When Bayer settled its Essure contraceptive lawsuits for $1.6 billion, the mega company resolved 90% of the nearly 39,000 defective product lawsuits pending against it. But at least one media outlet is asking, "Did a social media campaign began in 2011 and boasting more than 42,000 members influence Bayer to settle?" Read more on our blog.

Rheingold Giuffra Ruffo & Plotkin LLP 14.07.2020

Why is it that the drivers most likely to be involved in a car crash-teens and seniors-drive the worst cars in terms of safety devices? Yet, a new study finds that to be the case. Learn more on our blog.

Rheingold Giuffra Ruffo & Plotkin LLP 10.07.2020

Plaintiffs allege the design problems with the polypropylene mesh caused severe abdominal pain, infections, adhesions, erosion and other complications often resulting in the need for additional surgery to remove the failed hernia patch. Learn more here: